annual CFI:
-$358.91M-$90.57M(-33.75%)Summary
- As of today (June 17, 2025), GPCR annual cash flow from investing activities is -$358.91 million, with the most recent change of -$90.57 million (-33.75%) on December 31, 2024.
- During the last 3 years, GPCR annual CFI has fallen by -$376.77 million (-2109.68%).
- GPCR annual CFI is now -2109.68% below its all-time high of $17.86 million, reached on December 31, 2021.
Performance
GPCR Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$34.03M+$801.00K(+2.41%)Summary
- As of today (June 17, 2025), GPCR quarterly cash flow from investing activities is $34.03 million, with the most recent change of +$801.00 thousand (+2.41%) on March 31, 2025.
- Over the past year, GPCR quarterly CFI has increased by +$32.62 million (+2300.07%).
- GPCR quarterly CFI is now at all-time high.
Performance
GPCR quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$326.29M+$32.62M(+9.09%)Summary
- As of today (June 17, 2025), GPCR TTM cash flow from investing activities is -$326.29 million, with the most recent change of +$32.62 million (+9.09%) on March 31, 2025.
- Over the past year, GPCR TTM CFI has dropped by -$108.39 million (-49.74%).
- GPCR TTM CFI is now -721.53% below its all-time high of -$39.72 million, reached on March 1, 2022.
Performance
GPCR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GPCR Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.8% | +2300.1% | -49.7% |
| 3 y3 years | -2109.7% | +185.7% | -721.5% |
| 5 y5 years | -1597.2% | - | - |
GPCR Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2109.7% | at low | at high | +116.6% | -484.8% | +43.0% |
| 5 y | 5-year | -2109.7% | at low | at high | +116.6% | -721.5% | +43.0% |
| alltime | all time | -2109.7% | at low | at high | +116.6% | -721.5% | +43.0% |
GPCR Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $34.03M(+2.4%) | -$326.29M(-9.1%) |
| Dec 2024 | -$358.91M(+33.8%) | $33.23M(-117.6%) | -$358.91M(-37.4%) |
| Sep 2024 | - | -$189.04M(-7.6%) | -$572.88M(+62.0%) |
| Jun 2024 | - | -$204.51M(<-9900.0%) | -$353.71M(+62.3%) |
| Mar 2024 | - | $1.42M(-100.8%) | -$217.91M(-18.8%) |
| Dec 2023 | -$268.34M | -$180.74M(-699.9%) | -$268.34M(+247.3%) |
| Sep 2023 | - | $30.13M(-143.8%) | -$77.26M(-37.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$68.71M(+40.2%) | -$124.04M(+73.7%) |
| Mar 2023 | - | -$49.02M(-574.0%) | -$71.41M(+15.0%) |
| Dec 2022 | -$62.11M(-447.8%) | $10.34M(-162.1%) | -$62.11M(-14.3%) |
| Sep 2022 | - | -$16.66M(+3.6%) | -$72.45M(+29.9%) |
| Jun 2022 | - | -$16.07M(-59.5%) | -$55.79M(+40.5%) |
| Mar 2022 | - | -$39.72M | -$39.72M |
| Dec 2021 | $17.86M(-184.5%) | - | - |
| Dec 2020 | -$21.15M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Structure Therapeutics?
- What is Structure Therapeutics annual CFI year-on-year change?
- What is Structure Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFI year-on-year change?
- What is Structure Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Structure Therapeutics?
- What is Structure Therapeutics TTM CFI year-on-year change?
What is Structure Therapeutics annual cash flow from investing activities?
The current annual CFI of GPCR is -$358.91M
What is the all time high annual CFI for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from investing activities is $17.86M
What is Structure Therapeutics annual CFI year-on-year change?
Over the past year, GPCR annual cash flow from investing activities has changed by -$90.57M (-33.75%)
What is Structure Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of GPCR is $34.03M
What is the all time high quarterly CFI for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from investing activities is $34.03M
What is Structure Therapeutics quarterly CFI year-on-year change?
Over the past year, GPCR quarterly cash flow from investing activities has changed by +$32.62M (+2300.07%)
What is Structure Therapeutics TTM cash flow from investing activities?
The current TTM CFI of GPCR is -$326.29M
What is the all time high TTM CFI for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from investing activities is -$39.72M
What is Structure Therapeutics TTM CFI year-on-year change?
Over the past year, GPCR TTM cash flow from investing activities has changed by -$108.39M (-49.74%)